What Researchers Did
Researchers conducted an open-label randomized controlled trial to evaluate the effect of hyperbaric oxygen therapy (HBOT) on side effects and quality of life after pelvic radiation.
What They Found
In 32 patients receiving HBOT versus 33 controls, the acute side effect ratio was significantly lower in the HBOT group (0.7%) compared to controls (44.1%, p<0.001). Late side effects also decreased in the HBOT group (-19.6%) versus controls (33.6%, p=0.008). Quality of life improved more in the HBOT group (19.7%) compared to controls (4.5%) immediately after intervention (p<0.001) and at 6 months (15.2% vs 2.5%, p=0.007).
What This Means for Canadian Patients
Patients undergoing pelvic radiation who experience side effects might benefit from HBOT to alleviate symptoms and improve their overall well-being. This therapy could offer a non-invasive option to manage radiation-induced proctitis and enhance recovery.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
The study was open-label and conducted at a single center with a relatively small sample size.